Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
Q1 2026 vs. Q4 2025
How the institutions holding Sunshine Biopharma Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 13 | 12 | −1 |
| Shares | 115.0K | 122.2K | +7.21K (+6.3%) |
| Value | $141.7K | $127.1K | −$14.6K (−10.3%) |
New holders (3)
Institutions that held Sunshine Biopharma Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 23,482 | $24.4K | 0.00% |
| Commonwealth Equity Services, LLC | 13,437 | $14.0K | 0.00% |
| CoreCap Advisors, LLC | 1 | $1 | 0.00% |
Sold out (4)
Institutions that held Sunshine Biopharma Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Virtu Financial LLC | 23,388 | $29.0K |
| Bank of America Corp | 5 | $6 |
| SageView Advisory Group, LLC | 1 | $2 |
| Strive Financial Group ,LLC | 1 | $1 |